Get Your Personalized Supplement StackSupplement Stack Quiz

Pooleaa

Also known as: OEA, Pooleaa, Oleoylethanolamide

Overview

Oleoylethanolamide (OEA) is a naturally occurring fatty acid ethanolamide found in the small intestine, derived from oleic acid. It functions as an endogenous lipid signaling molecule primarily involved in the regulation of appetite and metabolism. As a dietary supplement and nutraceutical, OEA is primarily utilized for weight management, metabolic health improvement, and inflammation reduction. Its key characteristics include its crucial role in satiety signaling, which helps reduce food intake, and its notable anti-inflammatory effects. The research landscape for OEA is maturing, with an increasing number of clinical trials and meta-analyses being published. While the quality of evidence is improving, with several randomized controlled trials (RCTs) and meta-analyses available, there is still a need for more large-scale, long-term studies to fully establish its efficacy and safety profile.

Benefits

OEA supplementation has demonstrated significant evidence-based benefits, particularly in individuals who are overweight or metabolically compromised. Primary effects include substantial improvements in body weight, body mass index (BMI), waist circumference, fat mass, and body fat percentage, as evidenced by meta-analyses of randomized controlled trials. Glycemic control is also improved, indicated by reductions in fasting blood glucose, insulin levels, and insulin resistance (HOMA-IR). Furthermore, OEA exhibits anti-inflammatory properties, leading to reductions in C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α), and improves oxidative stress markers by increasing total antioxidant capacity and decreasing malondialdehyde. These benefits are statistically significant, with effects typically observed within weeks to months of consistent supplementation. However, OEA has not shown significant changes in fat-free mass, cholesterol fractions (LDL-C, HDL-C), or hemoglobin A1C.

How it works

Oleoylethanolamide (OEA) exerts its effects primarily through the activation of peroxisome proliferator-activated receptor-alpha (PPAR-α). This nuclear receptor plays a crucial role in regulating lipid metabolism and inflammatory responses within the body. OEA influences satiety by stimulating vagal afferent nerves, which transmit signals from the gut to the brain, and by modulating hypothalamic pathways involved in appetite control, thereby reducing overall food intake. Additionally, OEA modulates the production of inflammatory cytokines and pathways associated with oxidative stress, contributing to its anti-inflammatory and antioxidant effects. OEA is absorbed in the intestine and subsequently metabolized by fatty acid amide hydrolase (FAAH).

Side effects

Overall, Oleoylethanolamide (OEA) supplementation is considered well-tolerated, with no serious adverse events reported in clinical trials to date. Due to its endogenous nature, common side effects are minimal or not extensively documented. Currently, no significant drug interactions or contraindications have been established for OEA. However, it is important to note that there is insufficient data regarding the safety of OEA in special populations, such as pregnant or lactating individuals, and children. Therefore, its use in these groups is not recommended without further research. As with any supplement, individuals with pre-existing medical conditions or those taking other medications should consult a healthcare professional before starting OEA supplementation.

Dosage

Clinical trials investigating Oleoylethanolamide (OEA) have utilized a range of daily doses, typically from approximately 100 mg to 300 mg. While an optimal dosage has not been definitively established, a dose of 250 mg per day is commonly observed in studies that have demonstrated beneficial effects. There is currently no established maximum safe dose for OEA, and higher doses have not been extensively studied for their safety or efficacy. Due to its lipid nature, timing OEA supplementation with meals may enhance its absorption and bioavailability. It is advisable to start with a lower dose and gradually increase it while monitoring for effects, under the guidance of a healthcare professional.

FAQs

Is OEA safe for long-term use?

Current data suggest OEA has a good safety profile, but long-term studies are limited. Most research has focused on short to medium-term use, so more data is needed for definitive long-term safety conclusions.

How quickly does OEA work?

Effects on weight management, glycemic control, and inflammation can typically be observed within a few weeks to months of consistent OEA supplementation, according to clinical studies.

Does OEA cause fat-free mass loss?

No, studies have consistently shown that OEA supplementation does not lead to significant changes or loss in fat-free mass, focusing its effects primarily on fat reduction.

Is OEA effective alone or with diet/exercise?

Most studies on OEA's efficacy include lifestyle interventions like diet and exercise. OEA is likely most effective as a complement to these healthy habits, rather than a standalone solution.

Research Sources

https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1553288/full – This systematic review and meta-analysis of 10 RCTs found that OEA significantly improved weight, BMI, waist circumference, fat mass, glycemic control, inflammation, and oxidative stress. It noted no effect on fat-free mass or cholesterol, highlighting OEA's potential for metabolic health despite some heterogeneity and the need for longer-term data.
https://pubmed.ncbi.nlm.nih.gov/34130028/ – This systematic review and meta-analysis focused on omega-3 PUFAs, not OEA. It concluded that omega-3 PUFA supplementation did not improve muscle maintenance or body weight in cancer patients, providing a comparative context for different fatty acid derivatives.
https://pubmed.ncbi.nlm.nih.gov/31532492/ – This systematic review and meta-analysis on omega-3 PUFA supplementation found it reduced chemotherapy-induced neuropathy with low certainty. While not directly about OEA, it illustrates the research approach for fatty acid supplements and their varied effects.